A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

Overview of attention for article published in Trials, December 2020

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 208 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 77,608 followers.

RT @CastlDalmunzie: #IDtwitter #Cardiotwitter #clinicaltrial Effect of a combination of LMWH,aprotinin & anakinra on #thromboinflammatory r…

Reply Repost Favourite

#IDtwitter #Cardiotwitter #clinicaltrial Effect of a combination of LMWH,aprotinin & anakinra on #thromboinflammatory response & clinical outcome of #COVID19 patients. https://t.co/O3cZnk0M3I @BioMedCentral @HeartOTXHeartMD @mmamas1973 @DocSavageTJ

Reply Repost Favourite